Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein. Results of the first interim analysis of the GELA trial LNH98-B2

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 6505-6505
Author(s):  
P. Morel ◽  
N. Mounier ◽  
J. Brière ◽  
C. Ferme ◽  
B. Coiffier ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document